MedTrace Logo

Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*

NCT01240889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-10-10

No results posted yet for this study

Summary

This study will be a randomized, double blind, placebo-controlled, parallel group study and will include subjects with ragweed-induced seasonal allergic rhinitis.

Conditions

  • Allergy

Interventions

DRUG

Fluticasone

nasal spray

DRUG

Fluticason

2 sprays per day in each nostril

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Creighton University

    lead OTHER

Principal Investigators

  • Thomas B Casale, MD · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01240889 on ClinicalTrials.gov